1. INTRODUCTION

Understanding this hormonal link is essential for devising holistic treatments for stress-related metabolic disorders¹. The obesity epidemic has emerged as one of the most pressing public health challenges globally, with more than 650 million adults classified as obese according to the World Health Organization (2023). While excessive caloric intake and physical inactivity are primary drivers of obesity, recent research highlights the role of hormonal imbalances, particularly involving cortisol, in the pathophysiology of weight gain.

Cortisol, often termed the “stress hormone,” is released by the adrenal cortex as part of the body’s stress response. It exerts wide-ranging effects on metabolism, immunity, cardiovascular health, and behavior. Under acute stress, cortisol promotes adaptive responses such as increased glucose availability and anti-inflammatory effects. However, chronic stress or dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis can lead to persistently elevated or insufficient cortisol levels, disrupting metabolic processes and promoting adiposity, particularly in the abdominal region.

This paper seeks to examine the relationship between cortisol imbalance and weight gain through a comprehensive review of physiological mechanisms, clinical studies, diagnostic methodologies, and treatment strategies. By integrating current evidence from endocrinology, neuroscience, and nutrition science, we aim to provide a foundational understanding of this complex hormonal interaction².

2. Physiology of Cortisol:

Cortisol is a steroid hormone produced by the zona fasciculata of the adrenal cortex. It is a crucial component of the hypothalamic-pituitary-adrenal (HPA) axis and is primarily involved in the regulation of metabolism, immune response, and the body’s response to stress. Cortisol secretion follows a diurnal rhythm, peaking in the early morning (around 8a.m.) and reaching its lowest point around midnight³.

2.1. HPA Axis and Cortisol Regulation:

The HPA axis controls cortisol secretion through a feedback loop:

1. The hypothalamus releases corticotropin-releasing hormone (CRH) in response to stress.

2. CRH stimulates the anterior pituitary to secrete adrenocorticotropic hormone (ACTH).

3. ACTH acts on the adrenal cortex to produce and release cortisol.

4. Elevated cortisol levels exert negative feedback on the hypothalamus and pituitary to reduce CRH and ACTH secretion.

Figure 1 :The Hypothalamic-Pituitary-Adrenal (HPA) Axis⁴

2.2. Functions of Cortisol:

Cortisol’s effects are widespread due to the presence of glucocorticoid receptors in almost every cell type. Its main roles include:

· Metabolic regulation: Stimulates gluconeogenesis, lipolysis, and protein catabolism.

· Immune modulation: Suppresses inflammation and immune responses.

· Cardiovascular effects: Enhances vascular tone and blood pressure.

· Behavior and cognition: Affects mood, memory, and sleep.

Table 1: Major Functions of Cortisol⁵

Function	Description	Outcome
Glucose metabolism	Increases gluconeogenesis in the liver	Elevated blood glucose levels
Protein metabolism	Promotes protein breakdown in muscles	Amino acids for gluconeogenesis
Fat metabolism	Mobilizes fat stores, particularly visceral fat	Redistribution of fat
Immune function	Inhibits inflammatory cytokine production	Reduced inflammation, immune suppression
Cardiovascular system	Increases sensitivity to catecholamines	Maintains blood pressure
CNS effects	Influences mood, cognition, and sleep-wake cycles	Arousal, potential mood disorders

2.3. Circadian Rhythm and Cortisol:

The secretion of cortisol is under circadian control, with the highest levels occurring in the early morning. This rhythm is disrupted under conditions such as shift work, jet lag, or chronic stress, potentially leading to cortisol imbalance and associated metabolic consequences.

3. Causes of Cortisol Imbalance:

Cortisol imbalance can manifest as either hypercortisolemia (excess cortisol) or hypocortisolemia (insufficient cortisol). Both conditions disrupt homeostasis and contribute to metabolic dysfunction, including abnormal weight patterns. The primary causes of cortisol imbalance can be grouped into endogenous (disease-related) and exogenous (lifestyle or environmental) factors.

Cortisol imbalance can present as either excess or deficiency. Excess cortisol, seen in Cushing’s syndrome and chronic stress, leads to metabolic disturbances and weight gain. In contrast, low cortisol levels occur in conditions like Addison’s disease and pituitary damage, causing fatigue, low blood pressure, and weight loss. Both extremes disrupt normal physiological balance and require medical attention⁶.

Figure 2 :Types and Causes of Cortisol Imbalance⁶

3.1. Hyper-cortisolemia (Excess Cortisol):

3.1.1. Cushing’s Syndrome:

Cushing’s syndrome is characterized by chronically elevated cortisol levels, often due to an ACTH-secreting pituitary adenoma (Cushing’s disease) or adrenal tumors. Symptoms include central obesity, moon face, muscle weakness, and glucose intolerance.

3.1.2. Chronic Psychological Stress:

Sustained stress activates the HPA axis and leads to prolonged cortisol secretion. Modern psychosocial stressors (e.g., job strain, financial instability) are persistent and can result in long-term metabolic consequences, including visceral fat accumulation.

3.1.3. Depression and Anxiety:

Psychiatric disorders can dysregulate HPA axis activity. Major depressive disorder, in particular, is associated with higher baseline cortisol and a flattened diurnal rhythm, both of which are linked to weight gain.

3.2. Hypocortisolemia (Insufficient Cortisol):

3.2.1. Addison’s Disease:

An autoimmune condition leading to adrenal insufficiency. It results in low cortisol, fatigue, weight loss, hypotension, and electrolyte imbalances. While weight gain is not typical, erratic cortisol levels can affect metabolic stability.

3.2.2. Pituitary Dysfunction:

Damage to the pituitary (e.g., tumors, surgery, trauma) can impair ACTH production, resulting in secondary adrenal insufficiency.

3.2.3. Exogenous Steroid Withdrawal:

Long-term corticosteroid therapy suppresses endogenous cortisol production. Abrupt withdrawal can lead to temporary cortisol deficiency.

Table 2: Causes of Cortisol Imbalance and Their Effects⁷

Cause	Type of Imbalance	Mechanism	Effect on Weight
Cushing’s syndrome	Excess	Adrenal/pituitary tumor	Central obesity
Chronic psychological stress	Excess	Prolonged HPA axis activation	Visceral fat gain
Major depressive disorder	Excess	Flattened cortisol rhythm	Weight gain, cravings
Addison’s disease	Deficiency	Autoimmune destruction of adrenal cortex	Weight loss
Pituitary injury	Deficiency	Reduced ACTH secretion	Variable
Corticosteroid withdrawal	Deficiency	Suppression of endogenous cortisol	Temporary weight loss

4. Mechanisms Linking Cortisol and Weight Gain:

Cortisol’s influence on weight gain is multifactorial, involving metabolic, endocrine, neurological, and behavioral pathways. Chronic elevations in cortisol—whether due to stress, endocrine disorders, or exogenous sources—can lead to fat accumulation, particularly in the visceral (abdominal) region, as well as insulin resistance and altered appetite regulation.⁸

4.1. Metabolic Pathways:

Cortisol promotes gluconeogenesis and lipolysis, which are adaptive in the short term. However, persistent cortisol elevation leads to:

· Hyperglycemia, which increases insulin secretion.

· Insulin resistance, reducing glucose uptake by muscle and fat.

· Adipocyte hypertrophy, especially in visceral fat depots.

These changes create a cycle of fat storage and energy imbalance.

4.2. Adipose Tissue and Cortisol Sensitivity:⁹

Adipose tissue contains 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), an enzyme that converts inactive cortisone into active cortisol locally. This activity is especially high in visceral fat, leading to:

· Local cortisol amplification.

· Enhanced adipogenesis.

· Pro-inflammatory cytokine release (e.g., TNF-α, IL-6), which contributes to systemic insulin resistance.

4.3. Appetite and Reward Systems:

Cortisol influences appetite via central nervous system pathways:

· Increases ghrelin (the hunger hormone).

· Reduces leptin sensitivity, impairing satiety.

· Activates the mesolimbic dopamine system, enhancing cravings for high-fat, high-sugar foods ("comfort eating")

Figure 3: Cortisol’s Effects on Weight Regulation¹⁰

4.4. Sleep, Circadian Rhythm, and Cortisol:

Disrupted sleep (common in stress and shift work) dysregulates cortisol rhythms, leading to:

· Blunted morning cortisol peaks.

· Elevated evening cortisol, promoting nocturnal eating.

· Poor glucose metabolism during the night.

However, in cases of sleep disturbance, this rhythm becomes dysregulated. One hallmark of this disruption is a blunted morning cortisol peak, which is associated with reduced alertness and metabolic sluggishness. More critically, elevated evening or nocturnal cortisol levels are frequently observed in such individuals. This alteration not only promotes night-time hunger and food intake a behaviour linked with greater fat accumulation but also impairs nocturnal glucose metabolism, making the body less efficient at handling blood sugar during periods of rest. These physiological changes collectively contribute to an increased risk of central obesity, insulin resistance, and metabolic syndrome, particularly in individuals with irregular sleep-wake schedules.

Table 3: Mechanistic Pathways Linking Cortisol and Weight Gain¹¹

Mechanism	Description	Contribution to Weight Gain
Gluconeogenesis	Increases blood glucose levels	Promotes insulin secretion → fat storage
Insulin resistance	Reduces glucose uptake in muscles and adipose tissue	Enhances lipid storage, especially visceral
11β-HSD1 enzyme activity	Converts cortisone to cortisol in fat cells	Local cortisol amplification → fat accumulation
Appetite dysregulation	Increases ghrelin, reduces leptin sensitivity	Increased hunger and caloric intake
Reward system activation	Enhances craving for palatable foods	Overeating, preference for energy-dense food
Circadian rhythm disruption	Alters timing of cortisol secretion	Promotes night-time eating and fat storage

5. Clinical Studies and Evidence:

A growing body of clinical evidence supports the relationship between cortisol dysregulation and weight gain. These studies use a variety of methods, including salivary cortisol measurement, serum assays, and imaging of adipose tissue, to establish correlations between cortisol levels and body mass index (BMI), waist circumference, and metabolic parameters¹².

5.1. Cross-Sectional and Epidemiological Studies:

Numerous population-based studies have demonstrated a positive correlation between elevated cortisol levels and abdominal obesity.

· Brunner et al. (2002): In a cohort of 2,868 UK civil servants, higher cortisol reactivity to stress was associated with increased waist-to-hip ratio, independent of BMI.

· Rosmond et al. (2000): Found that men with abdominal obesity had higher morning cortisol and ACTH levels compared to controls.

5.2. Longitudinal Studies:

· Epel et al. (2001): A landmark study showing that women with higher cortisol reactivity to stress were more likely to have central fat accumulation over time.

· Vogelzangs et al. (2007): Demonstrated that elevated urinary cortisol levels predicted future increases in abdominal obesity in older adults ^[13].

5.3. Experimental Studies:

· Pruessner et al. (1999): Measured cortisol awakening response (CAR) in healthy adults and found that a blunted CAR was associated with higher body fat percentage.

· Kyrou and Tsigos (2009): Reviewed intervention trials showing that stress-reduction techniques (e.g., mindfulness, CBT) led to both reduced cortisol levels and modest weight loss.

5.4. Clinical Observations in Cushing’s Syndrome:

Cushing’s syndrome offers direct evidence of the effects of cortisol excess on body composition:¹⁴

· Patients typically present with central obesity, buffalo hump, muscle wasting, and insulin resistance.

· Bjorntorp (1997) argued that even “subclinical” hypercortisolism - without full-blown Cushing’s - may contribute to metabolic syndrome in the general population.

Multiple studies have shown a strong link between cortisol and fat accumulation. Brunner et al. (2002) and Epel et al. (2001) found that individuals with higher cortisol reactivity tended to have more central fat. Vogelzangs et al. (2007) reported that elevated cortisol predicted future increases in waist circumference. Rosmond et al. (2000) observed higher basal cortisol in obese Swedish men. Interventions reviewed by Kyrou and Tsigos (2009) showed that reducing stress lowered both cortisol levels and body weight. Additionally, Pruessner et al. (1999) found that a blunted cortisol awakening response was associated with higher body fat. These findings collectively suggest cortisol plays a key role in abdominal obesity¹⁵.

Table 4: Selected Clinical Studies on Cortisol and Weight Gain¹⁵

Study	Population	Key Finding	Conclusion
Brunner et al. (2002)	UK civil servants (n=2,868)	Higher cortisol reactivity linked to central fat	Stress response predicts abdominal obesity
Epel et al. (2001)	Healthy women	Stress-reactive individuals gained more fat	Cortisol reactivity → fat distribution
Vogelzangs et al. (2007)	Older adults	High cortisol → greater waist circumference later	Cortisol predicts future fat gain
Rosmond et al. (2000)	Swedish men	Obese individuals had higher basal cortisol	Cortisol linked to male abdominal obesity
Kyrou and Tsigos (2009)	Multiple RCTs	Stress reduction lowered cortisol and weight	Mind-body interventions are effective
Pruessner et al. (1999)	Healthy adults	Blunted CAR → higher body fat	Cortisol rhythm linked to adiposity

6. Diagnostic Methods:

Assessing cortisol imbalance is essential for diagnosing related metabolic disorders and guiding treatment. Cortisol can be measured in various biological matrices, each offering specific insights into acute or chronic hormonal activity. Clinical diagnosis also incorporates symptom evaluation, physical examination, and imaging, depending on suspected etiology (e.g., Cushing’s syndrome, Addison’s disease)¹⁶.

6.1. Biological Matrices for Cortisol Measurement:

6.1.1. Serum Cortisol:

· Typically used to measure basal cortisol or the response to stimulation/suppression tests.

· Reflects circulating cortisol at a single time point.

· Diurnal pattern: highest in the morning, lowest at night.

6.1.2. Salivary Cortisol:

· Non-invasive, reflects free (biologically active) cortisol.

· Used to measure the cortisol awakening response (CAR) and diurnal variation.

· Late-night salivary cortisol is highly sensitive for detecting Cushing’s syndrome.

6.1.3. 24-Hour Urinary Free Cortisol (UFC):

· Assesses cortisol secretion over a full day.

· Useful in diagnosing hypercortisolism.

· Requires accurate collection and compliance.

6.1.4. Dexamethasone Suppression Test (DST):

· Involves administering dexamethasone (a synthetic glucocorticoid) to suppress cortisol.

· Failure to suppress cortisol suggests Cushing’s syndrome or autonomous adrenal activity.

6.2. Diagnostic Criteria for Cortisol Disorders:

Cushing’s Syndrome:

· Elevated late-night salivary cortisol

· Elevated 24-hour UFC

· Abnormal DST result

· Imaging: CT or MRI to locate adrenal/pituitary lesions

Addison’s Disease:

· Low morning serum cortisol

· Low ACTH stimulation response

· Elevated ACTH (in primary adrenal insufficiency)

· Electrolyte abnormalities: hyponatremia, hyperkalemia

Table 5: Diagnostic Tools for Cortisol Evaluation¹⁷

Test Type	Sample Type	Purpose	Key Interpretation
Morning serum cortisol	Blood	Baseline cortisol levels	<5µg/Dl suggests adrenal insufficiency
Salivary cortisol	Saliva	Diurnal rhythm, Cushing's screening	↑ Late-night cortisol → suspect Cushing’s
24-hour urinary cortisol	Urine	Total daily cortisol output	>50 µg/day suggests hypercortisolism
Dexamethasone test	Blood (after oral dexamethasone)	Cortisol suppression capacity	No suppression → Cushing’s syndrome
ACTH stimulation test	Blood	Adrenal reserve capacity	Blunted response → adrenal insufficiency

6.3. Imaging and Functional Tests:

· MRI of the pituitary gland for suspected Cushing’s disease (ACTH-producing tumors).

· CT of the adrenal glands for adrenal adenomas or carcinomas.

· Insulin tolerance test (ITT) for evaluating HPA axis integrity in borderline cases.

6.4. Challenges in Cortisol Diagnosis:

· Cortisol levels fluctuate diurnally and are sensitive to external stress.

· Short-term cortisol spikes (e.g., due to anxiety or illness) can lead to false positives.

· Psychiatric disorders and medications (e.g., oral contraceptives, SSRIs) may interfere with cortisol metabolism and interpretation.

7. Therapeutic Approaches:

The management of cortisol imbalance aims to normalize cortisol levels, alleviate symptoms, and reduce the metabolic consequences such as weight gain, insulin resistance, and central adiposity. Treatment strategies vary by the underlying cause and severity-ranging from pharmacological therapies to lifestyle-based interventions that modulate the HPA axis¹⁸.

7.1. Pharmacological Interventions:

7.1.1. Treatment of Hypercortisolemia (e.g., Cushing’s Syndrome):

· Surgical Resection: First-line treatment for ACTH-secreting pituitary adenomas or cortisol-producing adrenal tumors.

Steroidogenesis Inhibitors:

· Ketoconazole: Inhibits cortisol synthesis; used in moderate cases.

· Metyrapone: Blocks 11β-hydroxylase, reducing cortisol production.

· Osilodrostat: A newer agent with potent cortisol-lowering effects.

Glucocorticoid Receptor Antagonists:

· Mifepristone: Used in cases of cortisol excess with hyperglycemia.

7.1.2. Treatment of Hypocortisolemia (e.g., Addison’s Disease):

Hormone Replacement Therapy:

· Hydrocortisone or Prednisone to replace deficient cortisol.

· Fludrocortisone for mineralocorticoid support in primary adrenal insufficiency.

· Patient education: Stress dosing during illness or surgery is crucial to prevent adrenal crisis.

7.2. Lifestyle and Behavioral Interventions:

Behavioral strategies are essential in managing stress-induced cortisol elevation and cortisol-mediated weight gain.

7.2.1. Stress Management:

· Mindfulness-Based Stress Reduction (MBSR): Reduces perceived stress and salivary cortisol.

· Cognitive Behavioral Therapy (CBT): Improves stress reappraisal and coping.

· Yoga and Meditation: Shown to blunt cortisol reactivity and reduce abdominal fat over time.

7.2.2. Physical Activity:

· Moderate-intensity aerobic exercise lowers basal cortisol and improves insulin sensitivity.

· High-intensity interval training (HIIT) may transiently raise cortisol, but long-term effects are beneficial.

7.2.3. Sleep Optimization:

· Improving sleep quality and duration restores circadian cortisol rhythm.

· Strategies include sleep hygiene, reducing blue light exposure, and treating insomnia with CBT-I.

7.3. Dietary Interventions:

· Low-glycemic diets help reduce insulin spikes and fat storage.

· Anti-inflammatory diets (rich in omega-3s, polyphenols) support HPA axis regulation.

· Avoiding stimulants (e.g., caffeine) in the evening minimizes cortisol elevation.

7.4. Emerging Treatments:

· 11β-HSD1 inhibitors: Under development to block cortisol activation in adipose tissue.

· Rhythmic glucocorticoid therapy: Mimics natural cortisol fluctuations to avoid metabolic side effects.

Treatment of cortisol-related weight gain involves both medical and lifestyle interventions. In cases of Cushing’s syndrome, surgical removal of pituitary or adrenal tumors can reduce cortisol levels and lead to weight loss. Steroid inhibitors such as ketoconazole, metyrapone, and osilodrostat are used to lower cortisol in hypercortisolism, helping decrease fat mass. For Addison’s disease, hormone replacement therapy with hydrocortisone or fludrocortisone helps stabilize metabolism. Psychological approaches like Cognitive Behavioral Therapy (CBT) and Mindfulness-Based Stress Reduction (MBSR) are effective in reducing cortisol elevated by stress, indirectly supporting weight loss. Regular exercise, especially aerobic and HIIT, helps modulate the HPA axis and increase fat oxidation. Sleep therapy, including improved sleep hygiene and CBT for insomnia, can restore normal cortisol rhythms and reduce night-time eating. Additionally, dietary changes that include low-glycemic and anti-inflammatory foods help regulate insulin sensitivity and support overall hormonal balance.

Table 6: Summary of Treatment Options for Cortisol Imbalance¹⁹

Treatment Type	Method	Target Condition	Effect on Weight
Surgery	Tumor removal (pituitary/ adrenal)	Cushing’s syndrome	Reduces cortisol; weight loss expected
Steroid inhibitors	Ketoconazole, metyrapone, osilodrostat	Hypercortisolism	Lower cortisol, reduce fat mass
Hormone replacement	Hydrocortisone, fludrocortisone	Addison’s disease	Stabilizes metabolism
CBT / MBSR	Psychological therapy	Stress-induced elevation	Lowers cortisol, supports weight loss
Exercise (aerobic/ HIIT)	Regular physical activity	General HPA modulation	Enhances fat oxidation
Sleep therapy	Improved sleep hygiene, CBT-I	Cortisol rhythm recovery	Reduces late-night eating
Dietary intervention	Low-GI, anti-inflammatory foods	Insulin resistance, HPA axis	Prevents fat gain, supports balance

8. Lifestyle and Behavioral Interventions in Detail:

Lifestyle factors profoundly influence cortisol levels and the risk of cortisol-related weight gain. Chronic psychological stress, poor sleep, unhealthy diet, and sedentary behaviour activate the HPA axis, creating a hormonal environment conducive to fat accumulation, particularly in the abdomen¹⁹.

8.1. Psychological Stress and Cortisol:

8.1.1. Mindfulness-Based Stress Reduction (MBSR):

· Structured program combining meditation, yoga, and awareness training.

· Studies show MBSR reduces salivary cortisol and perceived stress.

· Long-term practice correlates with decreased visceral fat and improved emotional regulation.

8.1.2. Cognitive Behavioral Therapy (CBT):

· Targets maladaptive thought patterns that perpetuate stress.

· Clinical trials show reductions in cortisol reactivity and improvements in dietary self-regulation.

8.2. Sleep and Circadian Rhythms:

Sleep deprivation or circadian misalignment leads to cortisol dysregulation and weight gain.

· Shortened sleep duration increases evening cortisol and appetite hormones (ghrelin).

· Sleep fragmentation is associated with insulin resistance and elevated BMI.

· CBT for insomnia (CBT-I) has been shown to reduce cortisol levels and improve metabolic outcomes.

8.3. Physical Activity:

Regular exercise can modulate HPA axis activity and reduce fat accumulation.

Aerobic Exercise (e.g., walking, swimming):

· Lowers basal cortisol levels.

· Enhances mood and reduces stress-induced eating.

Resistance Training:

· Promotes lean muscle mass, which improves metabolic rate.

· May acutely increase cortisol but is beneficial long term.

High-Intensity Interval Training (HIIT):

· Mixed evidence; cortisol rises acutely but long-term adaptations lower stress reactivity.

8.4. Diet and Nutritional Factors:

8.4.1. Low Glycemic Load Diet:

· Stabilizes blood sugar and insulin, preventing cortisol spikes.

· Reduces hunger and improves satiety.

8.4.2. Anti-Inflammatory Foods:

· Omega-3 fatty acids (fish, flaxseed), polyphenols (berries, green tea), and whole grains reduce systemic inflammation and cortisol activity.

8.4.3. Avoiding Stimulants:

· Caffeine and sugar elevate cortisol; intake should be moderated, especially in the afternoon and evening.

8.5. Integrative and Mind-Body Approaches:

· Yoga: Combines physical postures with breath control and meditation; shown to reduce cortisol and waist circumference.

· Tai Chi and Qi Gong: Gentle movement therapies that decrease cortisol and improve mood and metabolic parameters²⁰.

Table 7: Lifestyle Interventions for Cortisol Regulation and Weight Control²¹

Intervention	Mechanism of Action	Effect on Cortisol	Impact on Weight
MBSR	Enhances stress coping, reduces rumination	↓ Cortisol reactivity	↓ Visceral fat
CBT	Cognitive restructuring and behavior change	↓ Chronic stress patterns	↓ Emotional eating
Sleep hygiene / CBT-I	Restores circadian cortisol rhythm	↓ Evening cortisol	↓ Nighttime snacking
Aerobic exercise	Improves HPA axis sensitivity	↓ Basal cortisol	↑ Fat metabolism
Resistance training	Builds lean mass	Stabilizes cortisol	↑ Metabolic rate
Low-glycemic diet	Reduces insulin spikes	Prevents reactive cortisol	↓ Fat accumulation
Anti-inflammatory nutrition	Suppresses pro-inflammatory pathways	↓ Systemic cortisol activity	↓ Adiposity and cravings
Yoga / Tai Chi	Modulates autonomic and HPA activity	↓ Salivary cortisol	↑ Body-mind balance

9. CONCLUSION AND FUTURE DIRECTIONS:

Cortisol imbalance, particularly in the context of chronic stress and HPA axis dysregulation, plays a critical role in the pathogenesis of weight gain and obesity. Elevated cortisol levels promote central fat deposition, increase appetite for high-calorie foods, impair insulin sensitivity, and disrupt circadian rhythms- all of which converge to support metabolic dysfunction and long-term weight accumulation²².

This review has outlined the physiological mechanisms by which cortisol influences adipose tissue, examined clinical and epidemiological evidence linking cortisol to weight outcomes, and detailed diagnostic and therapeutic strategies. Effective management of cortisol-related weight gain requires a multidisciplinary approach, incorporating:

· Pharmacological therapies for pathological hypercortisolism or hypocortisolism,

· Behavioral and cognitive interventions to manage chronic stress,

· Lifestyle modifications that support circadian regulation and reduce inflammation.

Importantly, many individuals with cortisol-driven weight issues fall into a subclinical spectrum, without overt endocrine disease. This calls for early detection, particularly in populations exposed to high psychosocial stress, shift work, or chronic sleep disruption²².

9.1. Future Research Directions:

Despite advances, several knowledge gaps persist:

· Longitudinal studies are needed to clarify the temporal relationship between cortisol elevation and fat gain, particularly in adolescents and young adults.

· Biomarker discovery: More reliable indicators of chronic cortisol exposure (e.g., hair cortisol) may offer improved diagnostic accuracy.

· Personalized intervention trials are required to determine which stress-reduction or dietary strategies are most effective for different HPA axis profiles.

· Mechanistic studies on enzymes like 11β-HSD1 and glucocorticoid receptor polymorphisms could offer novel drug targets.

Finally, integrating endocrinology with behavioral science offers promising avenues for holistic treatment approaches that address both the biological and psychological dimensions of cortisol-related weight gain.

10. REFERENCES:

1. Björntorp P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition. 1997; 13(9): 795–800. doi:10.1016/S0899-9007(97)00127-5.

2. Brunner EJ, Hemingway H, Walker BR, Page M, Clarke P, Juneja M, et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome. Circulation. 2002; 106(21): 2659–65. doi:10.1161/01.CIR.0000038364.26310.BE.

3. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5(7):374–81. doi:10.1038/nrendo.2009.106.

4. Epel ES, McEwen BS, Seeman T, Matthews K, Castellazzo G, Brownell KD, et al. Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom Med. 2000; 62(5): 623–32. doi:10.1097/00006842-200009000-00005.

5. Epel E, Lapidus R, McEwen B, Brownell K. Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology. 2001; 26(1): 37–49. doi:10.1016/S0306-4530(00)00035-4.

6. Grossman A, Kelly P. Acute adrenal crisis. BMJ. 2016;353:i1858. doi:10.1136/bmj.i1858.

7. Kyrou I, Tsigos C. Stress mechanisms and metabolic complications. Horm Metab Res. 2009; 41(9): 625–33. doi:10.1055/s-0029-1220721.

8. Lustig RH. Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the first law of thermodynamics. Nat Clin Pract Endocrinol Metab. 2006;2(8):447–58. doi:10.1038/ncpendmet0226.

9. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007; 87(3): 873–904. doi:10.1152/physrev.00041.2006.

10. Pasquali R, Vicennati V, Cacciari M, Pagotto U. The hypothalamic–pituitary–adrenal axis activity in obesity and the metabolic syndrome. Ann N Y Acad Sci. 2006; 1083(1): 111–28. doi:10.1196/annals.1367.009.

11. Pruessner JC, Hellhammer DH, Kirschbaum C. Burnout, perceived stress, and cortisol responses to awakening. Psychosom Med. 1999; 61(2): 197–204. doi:10.1097/00006842-199903000-00010.

12. Rosmond R, Dallman MF, Björntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab. 1998; 83(6): 1853–9. doi:10.1210/jcem.83.6.4752.

13. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000; 21(1): 55–89. doi:10.1210/edrv.21.1.0389.

14. Stalder T, Kirschbaum C. Analysis of cortisol in hair–state of the art and future directions. Brain Behav Immun. 2012; 26(7): 1019–29. doi:10.1016/j.bbi.2012.02.002.

15. Tsigos C, Chrousos GP. Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002; 53(4): 865–71. doi:10.1016/S0022-3999(02)00429-4.

16. Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M, et al. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology. 2007; 32(2): 151–9. doi:10.1016/j.psyneuen.2006.11.009.

17. Walker BR. Cortisol—cause and cure for metabolic syndrome? Diabet Med. 2006; 23(12): 1281–8. doi:10.1111/j.1464-5491.2006.02017.x.

18. Whitworth JA, Williamson PM, Mangos G, Kelly JJ. Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag. 2005; 1(4): 291–9.

19. Wester VL, van Rossum EFC, Koper JW. Cortisol and the metabolic syndrome. J Clin Endocrinol Metab. 2015; 100(7): 2543–53. doi:10.1210/jc.2015-1448.

20. Yehuda R, Boisoneau D, Lowy MT, Giller EL. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry. 1995; 52(7): 583–93. doi:10.1001/archpsyc.1995.03950190039006.

21. Young EA, Abelson JL, Cameron OG. Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression. Biol Psychiatry. 2005; 57(12): 1170–6. doi:10.1016/j.biopsych.2005.02.027.

22. Zannas AS, Chrousos GP. Epigenetic programming by stress and glucocorticoids along the human lifespan. Mol Psychiatry. 2017; 22(5): 640–6. doi:10.1038/mp.2017.35.

Received on 20.06.2025 Revised on 25.07.2025

Accepted on 26.08.2025 Published on 11.10.2025

Available online from October 25, 2025

Res.J. Pharmacology and Pharmacodynamics.2025;17(4):319-326.

DOI: 10.52711/2321-5836.2025.00049

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.